Cancer | CHOP Research Institute
 

Cancer

Leftover Surgical Specimen Collection Study (Brain Tumor Focus)

The Philadelphia Coalition for a Cure (PC4C) study is interested in collecting blood and saliva samples from you, as well as leftover tissue and cerebrospinal fluid from surgeries at CHOP.

Center for Outcomes Research

Center for Outcomes Research

The Center for Outcomes Research is a multidisciplinary academic research center that employs rigorous outcomes research methodology to improve health and health care for children and adults.

‘Making Sure to Share Knowledge:’ Faculty Spotlight With Peter Choi, PhD

Published on
Mar 29, 2022
in Cornerstone Blog
Q&A With Peter Choi, PhD
Dr. Choi, our Faculty Spotlight scientist for March, discusses the important role of mentorship in academia.

In the News: Cancer Summit, Social Cues in Autism, Leigh Syndrome, Epilepsies

Published on
Mar 18, 2022
in Cornerstone Blog
In the News
This week in the news: a pediatric cancer summit, early diagnosis of Leigh Syndrome, quality of life in severe epilepsy, and more.

NIH New Innovator Award Supports Search for Answers in Splicing Codes and Cancer

Published on
Jan 13, 2022
in Cornerstone Blog
NIH Award Supports Search for Answers in Splicing Codes
Peter Choi, PhD, received the prestigious award for research into the hidden determinants of RNA splicing.

Snapshot Science: Do Very Sick Children’s Families Have More Mental, Physical Needs?

Published on
Dec 22, 2021
in Cornerstone Blog
Families of Children With Life-Threatening Conditions Need Care
CHOP researchers examine specific health effects faced by parents and siblings of very sick children and adolescents.

STAT Wunderkind "Blazing New Trails:" Q&A With Mark Yarmarkovich, PhD

Published on
Dec 15, 2021
in Cornerstone Blog
Q&A With STAT Wunderkind Mark Yarmarkovich, PhD
Dr. Mark Yarmarkovich, PhD, a senior scientist at CHOP, is a 2021 STAT Wunderkind.

MC² Program Energizes Research Between Mitochondrial Disease and Pediatric Cancer

Published on
Sep 22, 2021
in Cornerstone Blog
MC² Program Energizes Research Between Mitochondrial Disease and Pediatric Cancer
Marni Falk, MD, and Adam Resnick, PhD, to lead the Mitochondria and Cancer Connections (MC²) Research Program, a new CHOP research initiative.

Phase 1 Study Of Lentivirally Transduced T Cells Engineered To Contain Anti-CD123 In Subjects With Refractory Or Relapsed Acute Myeloid Leukemia

Phase 1 Study Of Lentivirally Transduced T Cells Engineered To Contain Anti-CD123 In Subjects With Refractory Or Relapsed Acute Myeloid Leukemia

Phase 1 open-label study to estimate the safety, manufacturing feasibility, and efficacy of intravenously administered, lentivirally transduced T cells expressing anti-CD123 in pediatric subjects with relapsed/refractory Acute Myeloid Leukemia.

PTEN Hamartoma Tumor Syndrome Phenotyping

PTEN Hamartoma Tumor Syndrome Phenotyping

This pilot study will assess these outcomes in children and young adults with PHTS ages 1 to 20 years.